PMS Review

Listen to this article You’ve held Dalal and Broacha Long Term Growth for a while, or you’re weighing whether to add it to a satellite sleeve. Either way, you’re here because trailing returns on a factsheet only tell you so much. You want to know if the fee is earning its place, and whether the […]

Listen to this article You’re looking at a PMS with a track record most strategies in this category simply don’t have — 23 years, live since June 2003. That’s long enough to have gone through the 2008 crisis, the 2013 taper tantrum, the 2018 mid-cap correction, the 2020 crash, and whatever 2025 threw at small […]

Quick Summary What Works What Doesn’t Strong alpha over 1-year, 2-year, 3-year, and since-inception periods 5-year alpha is negative — the one period that matters most to a real HNI holding period Zero exit load at any point — genuine flexibility to leave 2% flat fee (or hybrid fee) is high for a portfolio now […]

Listen to this article Quick Summary What Works What Doesn’t Positive alpha over the S&P BSE 500 TRI across the 2, 3, 5-year, and since-inception periods Sharply negative 1-year alpha (-3.76%) and a negative Sharpe Ratio (-0.64) — the most recent, most relevant window looks weak Highly experienced fund manager (Farokh Pandole — Harvard, Wharton, […]

Listen to this article Quick Summary What Works What Doesn’t Positive alpha over the S&P BSE 500 TRI across the 1, 2, 3, and 5-year trailing periods Since-inception alpha is essentially flat — the portfolio has matched, not beaten, its benchmark over the full cycle Experienced fund manager (28 years in Indian equities) with continuity […]

Listen to this article Quick Summary What Works What Doesn’t Genuine positive alpha over BSE 500 TRI across the 3-year (+3.23%), 4-year (+3.30%) and 5-year (+2.22%) trailing periods Alpha turns negative since inception (-0.34%) and over the trailing 2-year period (-0.43%) Real multi-cap flexibility in practice — 59.32% large cap, 21.77% mid cap, 14.98% small […]